Eirion Therapeutics Inc.
7 clinical trials · Sponsor
◉ Watch Eirion Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate AI-09 In Participants With Glabellar Lines (NCT07321834) | Eirion Therapeutics Inc. | 2025-12-03 |
| AI-09 In Subjects With Glabellar Lines, GL-101 (NCT05565950) | Eirion Therapeutics Inc. | 2022-09-03 |
| ET-01 in Subjects With Lateral Canthal Lines, LCL-210 (NCT04985916) | Eirion Therapeutics Inc. | 2021-07-19 |
| ET-01 in Subjects With Lateral Canthal Lines, LCL-208 (NCT03839693) | Eirion Therapeutics Inc. | 2018-10-16 |
| ET-01 in Subjects With Lateral Canthal Lines (NCT03326856) | Eirion Therapeutics Inc. | 2017-10-25 |
Track Eirion Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.